Ticker
AYTUCompany Name
AYTU BIOPHARMA INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Operating Margin | Operating Income | Revenues |
---|---|---|---|
6/30/2025 | -11.79% | $ -7.83M | $ 66.38M |
3/31/2025 | -5.57% | $ -3.85M | $ 69.22M |
12/31/2024 | -12.71% | $ -8.74M | $ 68.76M |
9/30/2024 | -6.2% | $ -4.68M | $ 75.48M |
6/30/2024 | -6.49% | $ -5.25M | $ 81M |
3/31/2024 | -2.03% | $ -1.9M | $ 93.76M |
12/31/2023 | -8.86% | $ -8.73M | $ 98.5M |
9/30/2023 | -17.56% | $ -17.89M | $ 101.84M |
6/30/2023 | -16.79% | $ -18.03M | $ 107.4M |
3/31/2023 | -34.24% | $ -35.65M | $ 104.11M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Op. Inc. / Revenues
(=) Operating %
Operating % for AYTU BIOPHARMA INC is calculated as follows: Op. Inc. [ $ -19.95M ] / Revenues [ $ 39.71M ]
(=) Operating % [ -50.24% ]
Minimum
Mar 31, 2022
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.27K |
---|---|
min | -71.54% |
max | 83.49% |
average | 9.05% |
median | 8.75% |
std | 23.74% |